Hartline Investment Corp Trims Position in Zoetis Inc. (NYSE:ZTS)

Hartline Investment Corp trimmed its position in shares of Zoetis Inc. (NYSE:ZTS) by 2.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,225 shares of the company’s stock after selling 244 shares during the quarter. Hartline Investment Corp’s holdings in Zoetis were worth $1,666,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Darwin Wealth Management LLC acquired a new position in shares of Zoetis during the third quarter worth about $31,000. First Personal Financial Services acquired a new position in shares of Zoetis during the third quarter worth about $33,000. Capital Performance Advisors LLP acquired a new position in shares of Zoetis during the third quarter worth about $33,000. Dunhill Financial LLC increased its stake in shares of Zoetis by 80.6% during the third quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock worth $33,000 after acquiring an additional 75 shares during the period. Finally, Fortitude Family Office LLC increased its stake in shares of Zoetis by 1,387.5% during the third quarter. Fortitude Family Office LLC now owns 238 shares of the company’s stock worth $46,000 after acquiring an additional 222 shares during the period. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Zoetis Stock Up 0.2 %

ZTS stock opened at $171.71 on Tuesday. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27. The firm has a market capitalization of $77.47 billion, a PE ratio of 32.28, a P/E/G ratio of 2.77 and a beta of 0.90. The company’s 50 day simple moving average is $169.26 and its 200-day simple moving average is $179.21. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $200.53.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Shareholders of record on Monday, April 21st will be issued a $0.50 dividend. The ex-dividend date is Monday, April 21st. This represents a $2.00 annualized dividend and a yield of 1.16%. Zoetis’s dividend payout ratio (DPR) is presently 37.59%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Leerink Partners assumed coverage on shares of Zoetis in a research report on Monday, December 2nd. They set an “outperform” rating and a $215.00 target price on the stock. Stifel Nicolaus lowered their target price on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. UBS Group assumed coverage on shares of Zoetis in a research report on Monday, December 9th. They set a “neutral” rating and a $196.00 target price on the stock. Morgan Stanley lowered their target price on shares of Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 29th. Finally, Piper Sandler lowered their target price on shares of Zoetis from $210.00 to $200.00 and set an “overweight” rating on the stock in a research report on Monday. One analyst has rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $214.00.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.